{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:32:54Z","timestamp":1772119974446,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To evaluate the value of MRI T1 mapping with Gd-EOB-DTPA for assessing liver function.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Seventy-two patients who underwent Gd-EOB-DTPA-enhanced MRI for focal liver lesions at Beijing Friendship Hospital from August 2020 to March 2022 were prospectively enrolled, and variable-flip-angle T1 mapping was performed before and 20\u00a0min after enhancement. The Child\u2013Pugh (C-P) score and albumin-bilirubin (ALBI) grade of liver function were assessed using the clinical data of the patients. Correlation analysis was used to evaluate the correlation between T1 mapping parameters and liver function grading and laboratory tests. Nonparametric tests were used to compare the differences among different liver function groups. The liver function classification efficiency of each image index was evaluated with receiver operating characteristic (ROC) curves.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>T1post was positively correlated with the C-P grade and the ALBI grade (<jats:italic>r<\/jats:italic>\u2009=\u20090.717 and <jats:italic>r<\/jats:italic>\u2009=\u20090.652). \u0394T1 was negatively correlated with the C-P grade and the ALBI grade (<jats:italic>r<\/jats:italic>\u2009=\u2009-0.790 and <jats:italic>r<\/jats:italic>\u2009=\u2009-0.658). T1post and \u0394T1 significantly differed among different liver function grades (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). For the C-P grade, T1post and \u0394T1 were significantly different between each pair of groups (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05), and \u0394T1 had a better diagnostic efficiency than T1post. For the ALBI grade, \u0394T1 and T1post were significantly different between the NLF and ALBI1 groups (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05), and \u0394T1 had a better diagnostic efficacy than T1post. T1post significantly differed between the ALBI1 and ALBI2\u2009+\u20093 groups (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05), while \u0394T1 had a weak ability to differentiate between these two groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>T1post and \u0394T1 were strongly correlated with the two liver function grades and can be noninvasive imaging indexes for evaluating liver function.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12880-023-01028-z","type":"journal-article","created":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T03:09:12Z","timestamp":1685934552000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Evaluation of liver function using Gd-EOB-DTPA-enhanced MRI with T1 mapping"],"prefix":"10.1186","volume":"23","author":[{"given":"Boyang","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinru","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinjun","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenghan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,5]]},"reference":[{"issue":"2","key":"1028_CR1","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000508172","volume":"37","author":"F Anger","year":"2021","unstructured":"Anger F, Klein I, L\u00f6b S, Wiegering A, Singh G, Sperl D, G\u00f6tze O, Geier A, Lock JF. Preoperative liver function guiding HCC resection in normal and cirrhotic liver. Visc Med. 2021;37(2):94\u2013101.","journal-title":"Visc Med"},{"key":"1028_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00534-004-0951-2","volume":"12","author":"J Belghiti","year":"2005","unstructured":"Belghiti J, Ogata S. Assessment of hepatic reserve for the indication of hepatic resection. J Hepatobiliary Pancreat Surg. 2005;12:1\u20133. https:\/\/doi.org\/10.1007\/s00534-004-0951-2.","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"1028_CR3","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/jmri.24248","volume":"39","author":"L Zhou","year":"2014","unstructured":"Zhou L, Chen TW, Zhang XM, et al. Liver dynamic contrast-enhanced MRI for staging liver fibrosis in a piglet model. J Magn Reson Imaging. 2014;39:872\u20138. https:\/\/doi.org\/10.1002\/jmri.24248.","journal-title":"J Magn Reson Imaging"},{"key":"1028_CR4","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1159\/000494844","volume":"8","author":"A Hiraoka","year":"2019","unstructured":"Hiraoka A, Kumada T, Michitaka K, Kudo M. Newly proposed ALBI grade and ALBI-T score as tools for assessment of hepatic function and prognosis in hepatocellular carcinoma patients. Liver Cancer. 2019;8:312\u201325. https:\/\/doi.org\/10.1159\/000494844.","journal-title":"Liver Cancer"},{"key":"1028_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1159\/000479984","volume":"6","author":"A Hiraoka","year":"2017","unstructured":"Hiraoka A, Michitaka K, Kumada T, et al. Validation and potential of albumin-bilirubin grade and prognostication in a nationwide survey of 46,681 hepatocellular carcinoma patients in Japan: the need for a more detailed evaluation of hepatic function. Liver Cancer. 2017;6:325\u201336. https:\/\/doi.org\/10.1159\/000479984.","journal-title":"Liver Cancer"},{"key":"1028_CR6","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000452846","volume":"6","author":"A Hiraoka","year":"2017","unstructured":"Hiraoka A, Kumada T, Kudo M, et al. Albumin-bilirubin (ALBI) grade as part of the evidence-based clinical practice guideline for HCC of the Japan society of hepatology: a comparison with the liver damage and child-pugh classifications. Liver Cancer. 2017;6:204\u201315. https:\/\/doi.org\/10.1159\/000452846.","journal-title":"Liver Cancer"},{"key":"1028_CR7","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/j.ejrad.2016.09.003","volume":"85","author":"Y Noda","year":"2016","unstructured":"Noda Y, Goshima S, Kajita K, Kawada H, Kawai N, Koyasu H, Matsuo M, Bae KT. Biliary tract enhancement in gadoxetic acid-enhanced MRI correlates with liver function biomarkers. Eur J Radiol. 2016;85:2001\u20137. https:\/\/doi.org\/10.1016\/j.ejrad.2016.09.003.","journal-title":"Eur J Radiol"},{"key":"1028_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12880-020-00519-7","volume":"20","author":"M Yang","year":"2020","unstructured":"Yang M, Zhang Y, Zhao W, Cheng W, Wang H, Guo S. Evaluation of liver function using liver parenchyma, spleen and portal vein signal intensities during the hepatobiliary phase in Gd-EOB-D TPA-enhanced MRI. BMC Med Imaging. 2020;20:119. https:\/\/doi.org\/10.1186\/s12880-020-00519-7.","journal-title":"BMC Med Imaging"},{"key":"1028_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1148\/radiol.2018180753","volume":"290","author":"JH Yoon","year":"2019","unstructured":"Yoon JH, Lee JM, Kang HJ, Ahn SJ, Yang H, Kim E, Okuaki T, Han JK. Quantitative assessment of liver function by using gadoxetic acid-enhanced MRI: hepatocyte uptake ratio. Radiology. 2019;290:125\u201333. https:\/\/doi.org\/10.1148\/radiol.2018180753.","journal-title":"Radiology"},{"key":"1028_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00330-019-06335-0","volume":"30","author":"J Li","year":"2020","unstructured":"Li J, Liu H, Zhang C, Yang S, Wang Y, Chen W, Li X, Wang D. Native T1 mapping compared to ultrasound elastography for staging and monitoring liver fibrosis: an animal study of repeatability, reproducibility, and accuracy. Eur Radiol. 2020;30:337\u201345. https:\/\/doi.org\/10.1007\/s00330-019-06335-0.","journal-title":"Eur Radiol"},{"key":"1028_CR11","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1007\/s00330-018-5947-4","volume":"29","author":"JE Kim","year":"2019","unstructured":"Kim JE, Kim HO, Bae K, Choi DS, Nickel D. T1 mapping for liver function evaluation in gadoxetic acid-enhanced MR imaging: comparison of look-locker inversion recovery and B(1) inhomogeneity-corrected variable flip angle method. Eur Radiol. 2019;29:3584\u201394. https:\/\/doi.org\/10.1007\/s00330-018-5947-4.","journal-title":"Eur Radiol"},{"key":"1028_CR12","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1200\/jco.2014.57.9151","volume":"33","author":"PJ Johnson","year":"2015","unstructured":"Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015;33:550\u20138. https:\/\/doi.org\/10.1200\/jco.2014.57.9151.","journal-title":"J Clin Oncol"},{"key":"1028_CR13","doi-asserted-by":"publisher","unstructured":"Expert consensus on enhanced MRI scanning protocol of hepatobiliary specific contrast agent gadoxetate disodium. Chin J Clin Hepatol. 2020:519\u2013521. https:\/\/doi.org\/10.3969\/j.issn.1001-5256.2020.03.008.","DOI":"10.3969\/j.issn.1001-5256.2020.03.008"},{"key":"1028_CR14","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.3760\/cma.j.issn.1005?1201.2019.12.010","volume":"12","author":"J Yu","year":"2019","unstructured":"Yu J, Qiu W, Li X, Zhou Z. The value of gadoxetate disodium-enhanced MR T1mapping combined with standard liver volume rate to assess liver function. Chin J Radiol. 2019;12:1076\u201380. https:\/\/doi.org\/10.3760\/cma.j.issn.1005?1201.2019.12.010.","journal-title":"Chin J Radiol"},{"key":"1028_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000315235","volume":"78 Suppl 1","author":"M Kudo","year":"2010","unstructured":"Kudo M. Will Gd-EOB-MRI change the diagnostic algorithm in hepatocellular carcinoma? Oncology. 2010;78 Suppl 1:87\u201393. https:\/\/doi.org\/10.1159\/000315235.","journal-title":"Oncology"},{"key":"1028_CR16","doi-asserted-by":"publisher","first-page":"15408","DOI":"10.1038\/srep15408","volume":"5","author":"N Verloh","year":"2015","unstructured":"Verloh N, Utpatel K, Haimerl M, Zeman F, Fellner C, Fichtner-Feigl S, Teufel A, Stroszczynski C, Evert M, Wiggermann P. Liver fibrosis and Gd-EOB-DTPA-enhanced MRI: a histopathologic correlation. Sci Rep. 2015;5:15408. https:\/\/doi.org\/10.1038\/srep15408.","journal-title":"Sci Rep"},{"issue":"6","key":"1028_CR17","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3390\/diagnostics11061125.PMID:34203008;PMCID:PMC8233916","volume":"11","author":"UL Fahlenkamp","year":"2021","unstructured":"Fahlenkamp UL, Kunkel J, Ziegeler K, Neumann K, Adams LC, Engel G, B\u00f6ker SM, Makowski MR. Correlation of native liver parenchyma T1 and T2 relaxation times and liver synthetic function tests: a pilot study. Diagnostics (Basel). 2021;11(6):1125. https:\/\/doi.org\/10.3390\/diagnostics11061125.PMID:34203008;PMCID:PMC8233916.","journal-title":"Diagnostics (Basel)"},{"issue":"10","key":"1028_CR18","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/nbm.2946","volume":"26","author":"JL Ulloa","year":"2013","unstructured":"Ulloa JL, Stahl S, Yates J, Woodhouse N, Kenna JG, Jones HB, Waterton JC, Hockings PD. Assessment of gadoxetate DCE-MRI as a biomarker of hepatobiliary transporter inhibition. NMR Biomed. 2013;26(10):1258\u201370. https:\/\/doi.org\/10.1002\/nbm.2946. Epub 2013 Apr 7. PMID: 23564602; PMCID: PMC3817526.","journal-title":"NMR Biomed"},{"key":"1028_CR19","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1124\/dmd.116.071050","volume":"44","author":"L Wang","year":"2016","unstructured":"Wang L, Collins C, Kelly EJ, et al. Transporter expression in liver tissue from subjects with alcoholic or hepatitis C cirrhosis quantified by targeted quantitative proteomics. Drug Metab Dispos. 2016;44:1752\u20138. https:\/\/doi.org\/10.1124\/dmd.116.071050.","journal-title":"Drug Metab Dispos"},{"key":"1028_CR20","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/j.1440-1746.2010.06494.x","volume":"26","author":"N Tsuda","year":"2011","unstructured":"Tsuda N, Harada K, Matsui O. Effect of change in transporter expression on gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging during hepatocarcinogenesis in rats. J Gastroenterol Hepatol. 2011;26:568\u201376. https:\/\/doi.org\/10.1111\/j.1440-1746.2010.06494.x.","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"1028_CR21","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s11547-021-01382-4","volume":"126","author":"J Li","year":"2021","unstructured":"Li J, Cao B, Bi X, Chen W, Wang L, Du Z, Zhang X, Yu X. Evaluation of liver function in patients with chronic hepatitis B using Gd-EOB-DTPA-enhanced T1 mapping at different acquisition time points: a feasibility study. Radiol Med. 2021;126(9):1149\u201358. https:\/\/doi.org\/10.1007\/s11547-021-01382-4. Epub 2021 Jun 8. PMID: 34105102.","journal-title":"Radiol Med"},{"key":"1028_CR22","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.3748\/wjg.v24.i18.2024","volume":"24","author":"S Pan","year":"2018","unstructured":"Pan S, Wang XQ, Guo QY. Quantitative assessment of hepatic fibrosis in chronic hepatitis B and C: T1 mapping on Gd-EOB-DTPA-enhanced liver magnetic resonance imaging. World J Gastroenterol. 2018;24:2024\u201335. https:\/\/doi.org\/10.3748\/wjg.v24.i18.2024.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1028_CR23","doi-asserted-by":"publisher","first-page":"4716","DOI":"10.1038\/s41598-022-08659-2","volume":"12","author":"VC Obmann","year":"2022","unstructured":"Obmann VC, Catucci D, Berzigotti A, Gr\u00e4ni C, Ebner L, Heverhagen JT, Christe A, Huber AT. T1 reduction rate with Gd-EOB-DTPA determines liver function on both 1.5 T and 3 T MRI. Sci Rep. 2022;12(1):4716. https:\/\/doi.org\/10.1038\/s41598-022-08659-2. PMID: 35304554; PMCID: PMC8933426.","journal-title":"Sci Rep"},{"key":"1028_CR24","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.hpb.2017.12.001","volume":"20","author":"CCN Chong","year":"2018","unstructured":"Chong CCN, Lee KF, Chu CM, et al. Microwave ablation provides better survival than liver resection for hepatocellular carcinoma in patients with borderline liver function: application of ALBI score to patient selection. HPB (Oxford). 2018;20:546\u201354. https:\/\/doi.org\/10.1016\/j.hpb.2017.12.001.","journal-title":"HPB (Oxford)"},{"key":"1028_CR25","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.clon.2016.11.012","volume":"29","author":"J King","year":"2017","unstructured":"King J, Palmer DH, Johnson P, et al. Sorafenib for the treatment of advanced hepatocellular cancer - a UK audit. Clin Oncol (R Coll Radiol). 2017;29:256\u201362. https:\/\/doi.org\/10.1016\/j.clon.2016.11.012.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"10","key":"1028_CR26","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.dld.2019.04.009","volume":"51","author":"D Ippolito","year":"2019","unstructured":"Ippolito D, Famularo S, Giani A, Orsini EB, Pecorelli A, Pinotti E, Gandola D, Romano F, Sironi S, Bernasconi DP, Gianotti L. Estimating liver function in a large cirrhotic cohort: signal intensity of gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced MRI. Dig Liver Dis. 2019;51(10):1438\u201345. https:\/\/doi.org\/10.1016\/j.dld.2019.04.009. Epub 2019 May 30. PMID: 31153787.","journal-title":"Dig Liver Dis"},{"key":"1028_CR27","doi-asserted-by":"publisher","unstructured":"Cheng D, Wan G, Sun L, Wang X, Ou W, Xing H. A novel diagnostic nomogram for noninvasive evaluating liver fibrosis in patients with chronic hepatitis B virus infection. Biomed Res Int. 2020:5218930. https:\/\/doi.org\/10.1155\/2020\/5218930. PMID: 32596321; PMCID: PMC7290880.","DOI":"10.1155\/2020\/5218930"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-023-01028-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-023-01028-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-023-01028-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T03:10:02Z","timestamp":1685934602000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-023-01028-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,5]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1028"],"URL":"https:\/\/doi.org\/10.1186\/s12880-023-01028-z","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,5]]},"assertion":[{"value":"5 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is prospective and was approved by the Bioethics Committee of Beijing Friendship Hospital, Capital Medical University (ethics approval No. 2020-P2-021-02).All procedures in this study were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards, and written informed consent was obtained from individual participants or their guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}